Technical Analysis for AKCA - Akcea Therapeutics, Inc.

Grade Last Price % Change Price Change
grade A 26.83 0.11% 0.03
AKCA closed up 0.11 percent on Wednesday, April 25, 2018, on 44 percent of normal volume.

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Up Up
See historical AKCA trend table...

Date Alert Name Type % Chg
Apr 25 Wide Bands Range Expansion 0.00%
Apr 24 Stochastic Reached Overbought Strength 0.11%
Apr 24 Wide Bands Range Expansion 0.11%
Apr 24 Overbought Stochastic Strength 0.11%
Apr 23 MACD Bullish Centerline Cross Bullish -3.18%
Apr 23 MACD Bullish Signal Line Cross Bullish -3.18%
Apr 23 Wide Bands Range Expansion -3.18%
Apr 23 Overbought Stochastic Strength -3.18%
Apr 20 Wide Bands Range Expansion 2.48%
Apr 20 Overbought Stochastic Strength 2.48%

Older signals for AKCA ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Akcea Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing drugs to treat patients with serious cardiometabolic diseases caused by lipid disorders. The Company's drugs, volanesorsen, AKCEA-APO(a)-LRx, AKCEA-ANGPTL3-LRx and AKCEA-APOCIII-LRx, are all based on antisense technology developed by Ionis Pharmaceuticals, Inc. (Ionis). The Company's volanesorsen drug has completed a Phase III clinical program for the treatment of familial chylomicronemia syndrome (FCS) and is currently in Phase III clinical development for the treatment of familial partial lipodystrophy (FPL). The Company's clinical pipeline contains drugs with the potential to treat inadequately addressed lipid disorders beyond elevated LDL-C that are contributing to the dramatic increase in the incidence of cardiometabolic disease, such as elevated triglycerides, oxidized phospholipids and other lipoproteins, such as lipoprotein(a), or Lp(a).
Is AKCA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 33.98
52 Week Low 8.1
Average Volume 382,233
200-Day Moving Average 0.0
50-Day Moving Average 23.8268
20-Day Moving Average 24.5675
10-Day Moving Average 24.916
Average True Range 2.0235
ADX 18.65
+DI 27.93
-DI 16.03
Chandelier Exit (Long, 3 ATRs ) 27.4295
Chandelier Exit (Short, 3 ATRs ) 27.1505
Upper Bollinger Band 28.5713
Lower Bollinger Band 20.5637
Percent B (%b) 0.78
BandWidth 32.594281
MACD Line 0.4653
MACD Signal Line 0.1615
MACD Histogram 0.3039
Fundamentals Value
Market Cap 1.72 Billion
Num Shares 63.9 Million
EPS -1.89
Price-to-Earnings (P/E) Ratio -14.20
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 28.90
Resistance 3 (R3) 28.75 27.90 28.56
Resistance 2 (R2) 27.90 27.38 27.98 28.44
Resistance 1 (R1) 27.37 27.05 27.64 27.52 28.32
Pivot Point 26.52 26.52 26.66 26.60 26.52
Support 1 (S1) 25.99 26.00 26.26 26.14 25.34
Support 2 (S2) 25.14 25.67 25.22 25.22
Support 3 (S3) 24.61 25.14 25.11
Support 4 (S4) 24.76